StockData
STENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends March 31

STERIS plc

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$221.97−0.69 (-0.31%)

Close on Oct 19, 2026

Market cap
$21.73B
P/E (TTM)
27.1
Dividend yield
1.11%

Earnings

Next report expected Nov 4, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q1 FY2027
Ended Jun 30, 2026
Aug 5, 2026After market close$1.50B$2.04$2.59
Q4 FY2026
Ended Mar 31, 2026
May 11, 2026After market close$1.60B$2.24$2.83
Q3 FY2026
Ended Dec 31, 2025
Feb 4, 2026After market close$1.50B$1.96$2.53
Q2 FY2026
Ended Sep 30, 2025
Nov 5, 2025After market close$1.50B$1.94$2.47
Q1 FY2026
Ended Jun 30, 2025
Aug 6, 2025After market close$1.40B$1.79$2.34
Q4 FY2025
Ended Mar 31, 2025
May 14, 2025After market close$1.50B$1.48$2.74
Q3 FY2025
Ended Dec 31, 2024
Feb 5, 2025After market close$1.40B$1.75$2.32
Q2 FY2025
Ended Sep 30, 2024
Nov 6, 2024After market close$1.30B$1.51$2.14
Q1 FY2025
Ended Jun 30, 2024
Aug 6, 2024After market close–––
Q4 FY2024
Ended Mar 31, 2024
May 8, 2024After market close–––
Q3 FY2024
Ended Dec 31, 2023
Feb 7, 2024After market close–––

Company guidance

Outlook given with results on Aug 5, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
capital expendituresfiscal 2027$450.00MRaised
Adjusted earnings per diluted sharenon-GAAPfiscal 2027$11.10 to $11.30Maintained
Net income from continuing operations per diluted shareGAAPFY 2027$8.92 to $9.12Lowered
Free cash flownon-GAAPfiscal 2027$800.00MLowered
Cash flows from operating activitiesGAAPFY 2027$1.25BNew
as reported revenue growthGAAPfiscal 20277% to 8% growthMaintained
constant currency organic revenue growthnon-GAAPfiscal 20276% to 7% growthMaintained

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Steris filed with the SEC